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ABSTRACT
How multicellular organisms obtain and use oxygen and other substrates has evolved over hundreds of mil-
lions of years in parallel with the evolution of oxygen-delivery systems. A steady supply of oxygen is critical
to the existence of organisms that depend on oxygen as a primary source of fuel (i.e., those that live by aero-
bic metabolism). Not surprisingly, a number of mechanisms have evolved to defend against oxygen depriva-
tion. This review highlights evolutionary and developmental aspects of O2 delivery to allow understanding of
adaptive responses to O2 deprivation (hypoxia). First, we consider how the drive for more efficient oxygen
delivery from the heart to the periphery may have shaped the evolution of the cardiovascular system, with
particular attention to the routing of oxygenated and deoxygenated blood in the cardiac outlet. Then we con-
sider the role of O2 in the morphogenesis of the cardiovascular system of animals of increasing size and com-
plexity. We conclude by suggesting areas for future research regarding the role of oxygen deprivation and
oxidative stress in the normal development of the heart and vasculature or in the pathogenesis of congenital
heart defects. Antioxid. Redox Signal. 9, 1339–1352.
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EVOLUTION OF OXYGEN
REQUIREMENTS, HYPOXIC 
STRESS RESPONSES, AND 
RESPIRATORY STRUCTURES
The early oxygen environment
O
XYGEN BEGAN TO ACCUMULATE on earth several billion
years ago in photosynthetic reactions in which energy
from the sun was used to convert carbon dioxide and water into
sugar, with oxygen as a waste product. The accumulation of
large amounts of oxygen was likely initially toxic, leading to
what is termed the Oxygen Catastrophe, also called the Oxy-
gen Crisis or Great Oxidation (40). This increase in environ-
mental oxygen  2.4 billion years ago is postulated to have
caused a massive die-off in obligate anaerobic organisms (bac-
teria) and may have provided the opportunity for expansion of
organisms that could both defend against oxidative stress and
use oxygen. Over time, O2x came to be highly abundant in the
earth’s air ( 21% O2/79% N2) and water (solubility of  5
ml/L), with the O2 content dependent on environmental factors
such as atmospheric pressure, temperature, and water salinity.
Evolution of biochemical/metabolic responses to
oxygen deprivation
That a continuous O2 supply was critical to the survival of
the simple multicellular eukaryotic aerobic organisms that first
evolved is suggested by the presence of a phyletically ancient
gene-based system to defend against changes in O2 availabil-
ity. The primary biochemical pathway for gene-based defenses
against O2 deprivation is the induction of the hypoxia-inducible
transcription factor (HIF) [reviewed in (87)] and elsewhere 
in this series]. The accumulation of the HIF-  subunit 
(-1, 2, 3) is suppressed under normoxic conditions by its hy-
droxylation by the prolyl 4-hydroxylases (PHD), a reaction in
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2University of North Texas, Denton, Texas.which O2 serves as a cofactor. The O2-dependent posttransla-
tional modification of HIF-  protein leads to binding of the von
Hippel–Lindau (VHL) factor followed by proteasomal degra-
dation. As O2x concentrations decrease, PHD activity is re-
duced, leading to accumulation of HIF- , which, through its
dimerization partner HIF-  (ARNT), binds DNA and regulates
the transcription of multiple hypoxia-responsive genes.
The constituents of this pathway were originally identified
in mammalian cells [reviewed in (62, 87, 95) and elsewhere in
this series]. Orthologues of HIF, PHD, and VHL have subse-
quently been identified throughout the animal kingdom, in-
cluding the nematode worm Caenorhabditis elegans (30, 48).
Adult C. elegans are only 1 mm in length and several cell lay-
ers thick. They have become a favored model organism because
of their simplicity at maturity ( 1,000 cells) combined with ev-
idence for conservation of life processes that are relevant to
more-complex animals. Oxygen delivery is accomplished by
diffusion from the surrounding medium. The presence in the
worm of a hypoxia/HIF-inducible transcriptional program (30,
48) suggests that it originally evolved as a cell autonomous sys-
tem for defense against O2 deprivation. Unlike larger and more
complex animals, C. elegans can survive at ambient O2 con-
centrations as low as 0.1%. Under O2 deprivation, C. elegans
reduces energy expenditure by limiting motility, feeding, and
metabolism (70, 71) .This strategy of energy conservation in
the setting of reduced O2 availability is used by worms and even
some lower vertebrates that are termed “hypoxia tolerant.” This
may be viewed as analogous to hibernation in more-complex
animals, as well as the downregulation of energy expenditure
in the face of reduced energy supplies that occurs in the myo-
cardial cells and other cell types of more-advanced organisms
(9, 19, 24, 111). In C. elegans and cells of other organisms, the
alternative strategy of increasing energy supply through a
switch to anaerobic metabolism (glycolysis) in response to O2
deprivation is also used (Pasteur effect). This is dependent on
the hypoxia/HIF-dependent upregulation of glucose trans-
porters and glycolytic enzymes. Because of the accumulation
of lactic acid as the byproduct of glycolysis, the switch to anaer-
obic metabolism by itself is self-limiting. Deletion of the HIF
gene from C. elegans limits survival in severe hypoxia (0.1%
O2) (48, 90), suggesting that the evolutionarily early function
of HIF was to promote cell survival under conditions of oxy-
gen deprivation, at least in part through induction of stress-re-
sponse genes and changes in cellular metabolism.
In C. elegans, as in almost all cells tested, hypoxia results in
the induction of the prolyl hydroxylases, serving as a negative-
feedback regulator of the hypoxic signal. In C. elegans, as in
other animals, some genomic responses to hypoxia are still ev-
ident after HIF ablation (90), suggesting HIF-independent
mechanisms for gene-based responses to hypoxic stress.
Whether these represent more-generalized stress responses, or
are specifically induced in response to O2 deprivation in a man-
ner analogous to HIF, is not yet clear.
Evolution of respiratory systems for 
oxygen acquisition
As larger, multicellular animals evolved, simple diffusion be-
came inadequate as a method of O2 delivery to tissues (Fig. 1).
The size at which a convective system for oxygen delivery is
required can be estimated based on the rate of diffusion of O2,
the O2 gradient driving diffusion, and O2 consumption. At sea
level, the partial pressure of O2 in the atmosphere is  150 mm
Hg, and assuming an anoxic core and Krogh’s constant of oxy-
gen diffusion of 0.045  mol/cm/sec/mm Hg, the maximum size
for effective O2 uptake by diffusion is  2 mm (15). Clearly, if
animals were to evolve into larger and more-complex organ-
isms, new systems for oxygen and substrate delivery and meta-
bolic waste removal would have to be developed. This is known
as the environmental gatekeeper theory for molecular oxygen,
which suggests that the Cambrian era explosion in biologic di-
versity came about as animals evolved systems for more-ef-
fective delivery and utilization of oxygen [reviewed in (55)].
The fruit fly Drosophila has an intermediate level of com-
plexity, with developed cardiac and respiratory systems. The
presence of these more-simplified organ systems, combined
with their ease of rearing and genetic manipulation via inser-
tional mutagenesis, has made the fruit fly a favored model or-
ganism for experimental study. The orthologues for the HIF-
dependent hypoxia signaling system have been described in a
number of invertebrates, including Drosophila and other in-
sects, and is thus thought to be common to arthropods and bi-
laterians [reviewed in (41)]. The cardiovascular systems of in-
sects and other arthropods do not contain O2-binding pigments
(hemoglobin in higher eucaryotes), and thus the circulating he-
molymph is thought not to play a role in oxygen transport. In-
stead, O2 delivery to the cells in these animals occurs primarily
via its distribution in gas through the tracheal system [reviewed
in (41)]. Tracheal cells are specified at midgestation Drosophila
under the control of the bHLH/PAS family member TRA-
CHEALESS, a binding partner for the HIF-1 /ARNT ortho-
logue TANGO [reviewed in (41)]. These cells then migrate to
regions where the tracheal system forms under the control of
the fibroblast growth factor (FGF) ligand and receptor ortho-
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FIG. 1. The relation between body size, metabolic rate, and
the ability of simple diffusion to provide adequate oxy-
genation of small animals. Generally, animals falling in the
“diffusion zone” on this figure can supply all of their oxygen
needs by diffusion, but as body size or metabolic rate or both
increase, the need for an internal convection of body fluids in-
creases. Exceptions are large animals with unusually low meta-
bolic rates, or small animal with unusually large metabolic rates.
(From Burggren and Reiber, 2007).logues BRANCHLESS and BREATHLESS, respectively.
FGFs also play a role in a number of morphogenic processes
of the respiratory and cardiovascular systems of vertebrates
(102); it is not known whether this represents some degree of
evolutionary conservation of function. Although some of the
details remain to be worked out, a role for hypoxia/HIF in the
establishment and repair of the tracheal O2 delivery system of
arthropods seems likely (4). Oxygen may also control other fly
body characteristics (e.g., body size), through an effect on in-
sulin/PI3K/TOR signaling (92).
EVOLUTION OF CARDIOVASCULAR
SYSTEMS IN VERTEBRATES
Increasing size and complexity as a driver of
cardiovascular development
As body size increased beyond the ability of diffusion to
serve it, internal cardiovascular systems evolved to provide in-
ternal transport of respiratory gases, nutrients, and metabolic
wastes. The evolution of vertebrates with increasing energy de-
mands required high-pressure/high-output systems for O2 de-
livery to meet the increasing O2 and nutrient demand. One dri-
ver of the increasing demand was likely body size itself, with
the ratio of surface area to mass being a key determinant of an
organism’s resting metabolic rate. This, along with large, spe-
cialized organs with high energy demands, such as the heart
and brain, dictated the need for a delivery system that was ca-
pable of greater O2 delivery and not subject to the whims of
environmental change. Perhaps the most significant develop-
ment in the increasing demand on cardiovascular function in
vertebrates was the evolution of endothermy and the emergence
of warm-blooded birds and mammals. Endotherms, whose ac-
tivity is not dependent on environmental temperature, have an
O2 consumption typically 10-fold greater than that of the ec-
totherms, such as reptiles and amphibians. Correspondingly,
birds and mammals require a constant internal convective sup-
ply of O2 to meet the metabolic demands of the tissues.
The basic vertebrate circulatory plan
The basic cardiovascular plan of vertebrates comprises a
muscular pump, the heart, ejecting blood into the arterial vas-
cular network. Oxygen is off-loaded from hemoglobin into
respiring cells. The deoxygenated blood returns toward the heart
through the venous vascular network, and the cycle of oxy-
genation of blood and its recirculation is repeated. The general
conservation of this system through the vertebrate classes, as
well as evidence for conserved transcriptional pathways that di-
rect cardiac morphogenesis, has led to the hypothesis that the
cardiovascular system of more-complex vertebrates represents
the modular addition of repetitive elements onto the basic sin-
gle-chamber heart pump [reviewed in (69)]. In this review, we
explore the hypothesis that, subsequent to the formation of the
basic template, the development of increasing complexities of
the vertebrate heart was a series of adaptations to optimize O2
delivery to tissues with increasing yet variable metabolic de-
mands. First, we describe these arrangements in the different
taxa, starting with the more phyletically ancient animals, the
fishes, and moving on to more energetically demanding warm-
blooded birds and mammals. A comprehensive comparative an-
atomic and physiologic review of these systems is beyond the
scope of this review, and the reader is directed to other sources
[see (17, 57)]. Here we focus on specific aspects of heart and
vascular development that are likely to be shaped by oxygen
demand.1
Fish
The circulatory system of a hypothetical ancestor of all of
the vertebrates was one in which a structurally simple heart
pumped blood via a simple, valved outflow tract (OFT) into a
single, ventrally located aorta. From there, blood passed through
a large number of cephalic aortic arches in proximity to the
gills, where oxygenation of the blood would occur. The oxy-
genated blood then passed into the dorsal aorta and was dis-
tributed to the tissues. The heart received deoxygenated blood
from the tissues, and its ejection into the ventral aorta would
reinitiate a new cycle. 
In this circulation plan, blood is pumped to the oxygenating
organs (gills and, to a lesser extent, skin) and then to the pe-
riphery and thus represents a single-pump “in-series circula-
tion” (Fig. 2). The circulations of both cartilaginous (elasmo-
branch) and bony (teleost) fish have retained the series
arrangement with four specialized chambers: the sinus venosus
and atrium, which receive the blood; the muscular ventricle,
which pumps the blood; and an outlet chamber, with variable
morphology, designated as either the bulbus or conus arterio-
sus, which is thought to aid in the expulsion of blood into the
main artery through a “windkessel” effect (17, 76, 85). Aside
from the characteristics of an “in-series circulation” (discussed
later), two unique traits of the fish heart morphology exist that
we concentrate on in this thesis that O2 requirements played a
major role in shaping the development of the heart. The first
trait involves the heart’s outlet tracts. The development of air-
breathing organs (not only true lungs, but other bladder-like res-
piratory organs) followed by the migration onto land, provided
both a rich source of O2 and release from the tyranny of po-
tential daily or seasonal aquatic hypoxic exposure. However,
the evolution of an air-breathing organ in fishes that retained
gills (as do almost all air-breathing fishes) required a more-
elaborate vascular structure that would minimize if not elimi-
nate the intracardiac mixing of oxygenated blood returning from
the air-breathing organ with deoxygenated blood returning from
metabolizing tissues (and possibly poorly oxygenated blood
draining gills that were ventilated with hypoxic water). Achiev-
ing this separation required significant changes to the outlet
tract of the heart, including new vessels, spiral valves within
existing vessels, etc., as well as the development of separate
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1Each of the major vertebrate groups—fishes, amphibians, reptiles,
birds, and mammals—has generated considerable diversity as they
adapt to extreme environments. Given this, the dictum that “ontogeny
recapitulates phylogeny” is not accurate in a strict sense (i.e., the fish
cardiovascular system is not ancestral to that of birds and mammals).
Nonetheless, these taxa shared common ancestors, and comparisons of
their organ systems is useful in considering how these systems may
have adapted and evolved to various pressures, considered here in the
context of O2 availability and demand.venous structures carrying oxygenated blood back to the heart
(analogous, if not homologous, with a pulmonary vein) (Fig.
3). Moreover, the variability in gas-exchange organs (skin, gills,
lungs, nonpulmonary air bladders, even specialized regions of
the gut) has also likely contributed to the great variability in
cardiac OFTs between classes.
Increased body size and metabolic requirements also required
increased work of the heart to meet these demands. This re-
quired a dedicated supply of well-oxygenated blood to the heart
tissue itself. In some fishes (e.g., salmonid fishes), a dense com-
pact layer of myocardium is supplied with oxygenated blood
through dedicated coronary arteries, whereas an inner trabecu-
lar (spongy) layer is bathed in relatively deoxygenated venous
blood (17, 32, 85). However, in many fishes, coronary arteries
are absent or rudimentary, and a highly trabecular myocardium
is supplied with O2 primarily by diffusion from the O2-poor ve-
nous blood moving in and out of the trabecular pockets in the
heart wall.
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FIG. 2. General schematics of the vertebrate
circulatory patterns, showing the relations be-
tween the heart and the gas-exchange organs(s)
of each circulation. From Burggren and Reiber
(2006) after Hicks (2002).
FIG. 3. Gross morphology of
the outflow tract(s) of the heart
of representative lower verte-
brates. The patterns of flow of
oxygenated and deoxygenated
blood through each of these
hearts is surprisingly complex,
involving both spatial and tem-
poral components to maintaining
separation of bloodstreams. (For
description of blood-flow pat-
terns and literature sources, see
Burggren et al., 1997).Amphibians
The amphibians, such as frogs and salamanders, demonstrate
a rather interesting arrangement in which two potential sites of
O2 uptake, the lungs and the skin, are arranged in parallel (Fig.
2) (14, 17). Deoxygenated blood returning from the systemic
circulation mixes in the right atrium with relatively oxygenated
blood returning from the skin. Oxygenated blood returns from
the relatively large, saccular lungs to the left atrium. Both blood-
streams enter a single ventricle and are ejected via a single OFT
into a single-outlet structure (Fig. 3). However, the heavily tra-
beculated ventricle and the spiral valve that runs longitudinally
down the proximal part of the outflow vessel direct primarily
oxygenated blood to the arterial arches and on to the systemic
circulation and direct primarily deoxygenated blood into the
pulmocutaneous circulation for subsequent oxygenation. The
ratio of blood flow between the systemic and pulmocutaneous
circuits (and indeed between the cutaneous and pulmonary ar-
teries) is regulated in the short term depending on oxygen de-
mands of the tissues and the pattern of pulmonary ventilation
(89). The absence of complete septation of the OFT and ven-
tricle that would force two separate, parallel circuits of identi-
cal volume, as occurs in birds and mammals, is thus advanta-
geous in amphibians, allowing switching between cutaneous
and pulmonary O2 sources depending on O2 availability in the
lungs of these intermittent breathers.
Reptiles
Reptilians also have an incompletely divided systemic and
pulmonary circulation, representing a functionally (though not
structurally) intermediate position in terms of bloodstream sep-
aration (see Fig. 2). Turtles, nonvaranid lizards, and snakes have
two separate atria emptying into a complexly structured ven-
tricle best described as having three separate cava (see Fig. 3).
Not surprisingly, intracardiac blood-flow patterns in noncroco-
dilian reptiles are complex, but still yield both left-to-right (sys-
temic bypass) and right-to-left (pulmonary bypass) shunts.
Among the reptiles, only the crocodilians have a structurally
separate left and right ventricle, reflecting the avian and mam-
malian condition in which no intracardiac mixing of oxygenated
and deoxygenated blood occurs. However, in crocodilians, the
presence of a left aorta arising from the left ventricle, and a
foramen of panizzae allowing connection between the aortic
bases, still provides the capability of a right-to-left shunt. As in
the case of the amphibians, it is likely that the intra- or extrac-
ardiac shunting of blood is a highly effective adaptation for an
intermittently breathing, diving animal with waxing and wan-
ing pulmonary oxygen stores (16, 45).
Birds and mammals
Whereas birds and mammals are thought to have evolved
separately from reptile-like ancestors, their cardiovascular sys-
tems bear much in common, probably reflecting the similari-
ties of high metabolic rate and correspondingly high O2 de-
mand. In adult birds and mammals, mixing of oxygenated and
deoxygenated blood is prevented by an in-series circulation
powered by two separate pumps within the heart (see Fig. 2).
Deoxygenated blood enters the right atrium and flows on to the
right ventricle, where it is ejected into the pulmonary artery,
destined for the lungs. As blood passes through the pulmonary
alveoli, hemoglobin in the red blood cells becomes saturated
with O2, and HCO3
  in plasma and within erythrocytes is re-
converted to molecular CO2, which diffuses out into alveolar
gas. Oxygenated blood returns to the heart via the pulmonary
veins into the left atrium, flows into the left ventricle, and is
ejected into the aorta and the systemic circulation. Thus, the
aortic and pulmonary arteries (cardiac outlet) and the right and
left ventricles are completely separated by septae. An extensive
coronary arterial system directly provides O2 (saturating the red
blood cell hemoglobin) and nutrients to the working myo-
cardium of the left and right ventricles. A significant failure of
functional separation of pulmonary and systemic circulations in
humans and other mammals can result from congenital defects
in cardiac septation or abnormal positioning of the great ves-
sels, and other OFT anomalies (33, 58, 105). The ejection of
partially oxygenated blood into the systemic circulation as oc-
curs in what are collectively termed conotruncal heart defects
(tetralogy of Fallot, double-outlet right ventricle, transposition
of the great arteries, and persistent truncus arteriosus, Fig. 4),
along with the increased hemodynamic burden, is usually
poorly tolerated, resulting in reduced functional capacity, and,
if not surgically corrected, limited survival.
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FIG. 4. Congenital defects in the human cardiac outlet struc-
tures (conotruncus) that result in right-to-left shunting of de-
oxygenated blood. These defects are postulated to arise from
malrotation of the OFT or myocardial infundibular defects or both.
DORV, Double-outlet right ventricle. Both great vessels (Ao,
aorta; and PA, pulmonary artery) connect via the myocardial in-
fundibulum to the right ventricle. TGA, Transposition of the great
arteries. The Ao connects via the infundibulum to the RV, and
the PA directly connects to the LV. ToF, Tetralogy of Fallot. Pul-
monic stenosis is secondary to infundibular hypoplasia, and the
aorta is malrotated and thus partially overrides the right ventricle.
These defects are associated with ventricular septal defects, which
provide a necessary conduit for blood flow. Although shown as
individual entities, these dysmorphologies represent a spectrum
of defects in the conotruncal structures.We have now reviewed the evolution of the cardiac struc-
tures and particularly the cardiac OFT. We have done this in
the context of the common assumption that the dual-series cir-
culation, in which deoxygenated blood transits the pulmonary
circuit and oxygenated blood transits the systemic circuit,
evolved to deliver oxygen more efficiently to the tissues in
warm-blooded birds and mammals. We next consider the nec-
essary corollary that tissue hypoxia is a driver of the develop-
ment of the dual in-series circulation in the developing avian
and mammalian embryo.
INFLUENCE OF HYPOXIA IN
CARDIOVASCULAR DEVELOPMENT
All embryos begin as a single cell created by the fusion of a
sperm and egg. The growing zygote must then obtain a source
of O2 and other substrates that will provide the energy needed
for continued development and growth. That tissue hypoxia and
subsequent HIF-dependent transcription is required for normal
development is strongly suggested by the results of gene-inac-
tivation studies in mice. In experiments in which HIF family
members ARNT (HIF-1 ) or HIF-1  are inactivated in the
germline, the mouse embryo fails to develop past mid-gesta-
tion [reviewed in (92)]. Here we consider the evidence that O2
deprivation and the resultant transcriptional response plays a
key role in the development of specific heart and vascular struc-
tures of the vertebrate embryo.
Development of placenta and 
chorioallantoic membrane
Based on studies using avian models, the early endotherm
embryo initially derives its O2 and nutrient supply by simple
diffusion, falling within the “diffusion zone” (based on size and
oxygen consumption) indicated in Fig. 1, much as in its sim-
ple, avascular primitive ancestors. However, as the embryo
rapidly grows, its O2 demand outstrips diffusional oxygen de-
livery, and the internal circulation (which has already begun to
form and propel blood) takes on an increasingly important func-
tion in convective gas transport (13, 15). In mammals, concur-
rent with the elaboration of the embryonic circulation, the pla-
centa forms as a necessary interface for gas and nutrient
exchange with the maternal circulation. The placenta forms by
the invasion of cytotrophoblasts from the embryo into the uter-
ine wall in an oxygen-dependent process, with striking resem-
blance to tissue invasion in the process of angiogenesis. The
behavior of the cytotrophoblasts is oxygen dependent: these
cells proliferate under the severely hypoxic conditions ( 2%
O2) that mimic the uterine environment before placentation (36,
114). When exposed in vitro to higher O2 concentrations, as
would occur as the invading cells approach the uterine arteri-
oles, the cytotrophoblasts differentiate to form the syncytium
that makes up the uteropacental unit for exchange of gas and
nutrients (37). Inactivation of the ARNT (HIF-1 ) gene in the
germline results in defects in the placenta and early demise of
the embryo, likely due to defective hypoxia-dependent differ-
entiation of the trophoblastic cells (2, 60). That the placenta-
tion is finely regulated by O2 levels and transcriptional re-
sponses is indicated by the defects in placentation that also are
caused by HIF gain of function induced by germline inactiva-
tion of PHD2 (99).
In the egg-bound embryos of birds, respiration is achieved
throughout all but the last hours before hatching by the exten-
sive vessels of the chorioallantoic membrane, with perfusion
supplied by the vitelline arteries and veins of the yolk sac (100,
101). The yolk sac in birds and mammals is also the site of ori-
gin of the hemangioblast, the primitive common precursor of
both blood and endothelial cells. Studies of these and other stem
cells suggest that their development also is oxygen sensitive
(75), a topic beyond the scope of this review. The formation of
the vitelline circulation on the yolk sac is evident within 1 day
after the formation of the pigmented blood islands [i.e., at  48
h of development in the chicken embryo (reviewed in ref. 6)].
According to the more-precise staging of Hamburger and
Hamilton (43), this would be approximately stage 15. At this
early stage, the heart has begun to beat, and a functional closed
circulation is developed. This is much earlier than the mam-
malian embryo, in which in the mouse, the placental circula-
tion is first established, followed by a closed functional em-
bryonic circulation, at days 10–12, or  50% of prenatal
development. In the chicken embryo, the allantois fuses with
the chorionic membrane, forming the chorioallantoic membrane
(CAM) at about day 8, well after the heart has formed, and then
serves as the primary site of gas exchange for the remainder of
the incubation. Thus, the timing of the maturation of the mouse
(mammalian) gas exchanger and cardiovascular system is both
different and compressed relative to that of the chicken embryo,
which must support itself from the early stages of development.
Despite these differences, both models will continue to prove
useful to understand vertebrate cardiovascular development.
Oxygen delivery to the developing embryo and
fetal tissues
To discuss the role of tissue O2 in embryonic cardiovascular
morphogenesis, we must first consider O2 delivery to the em-
bryo. The mammalian placenta takes many different forms [re-
viewed in (29, 110)]. In all cases, O2 readily passes through the
placenta by simple diffusion, as governed by Fick’s law of dif-
fusion,
dm/dt   DF(C1   C2)/b
where dm/dt is the amount of gas transferred per unit time, D
is the diffusion coefficient, F is the area of exchange, and (C1
 C2) is the partial pressure gradient between maternal and fe-
tal circulations. It is estimated that the partial pressure of O2
traveling from the placenta to the fetus via the umbilical vein
is  30 mm Hg, providing 80% saturation of the blood hemo-
globin. In the mammalian fetal circulation, blood is shunted at
three levels: the ductus venosus, bypassing the liver, and fora-
men ovale and ductus arteriosus, providing a right-to-left shunt-
ing of blood away from the pulmonary circulation and the lungs,
which do not function in gas exchange in the fetus. This arrange-
ment is more reminiscent of a parallel circulation of a lower
vertebrate as compared with the series circulation of the adult
human (Fig. 2). A full consideration of fetal blood shunting is
beyond the scope of this review. However, of relevance is that
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ment: transition from the more-
primitive single circulation (stage
25, ED5) to the mature dual in-
series configuration (stage 36,
ED10). Development and remod-
eling of the embryonic chick car-
diac OFT (A). The OFT my-
ocardium of the stage 25 (ED5) and
stage 36 (ED10) chick heart is la-
beled with red fluorescent protein
expressed from recombinant ade-
novirus. The lumens of the hearts
and vessels are filled with blue ink
in (A) and blood in (B). In this de-
velopmental window (1), the OFT
myocardium shortens and commits
to the right heart, forming the sub-
pulmonic infundibulum. The OFT
rotates, placing the aorta in a pos-
terior position to connect with the
LV; (2) the OFT, ventricles, and atria are septated to divide the left and right circulations; (3) the coronary arteries form to supply the
working myocardium with well oxygenated blood; (4) the cushion mesenchyme is remodeled to from the valves and other structures
(not shown). [Reprinted with permission from Trends in Cardiovascular Medicine (98)]. (For interpretation of the references to color
in this figure legend, the reader is referred to the web version of this article at www.liebertonline.com/ars)
the mixing of blood with differing O2 contents occurs at mul-
tiple sites, resulting in O2 saturations of hemoglobin in the sys-
temic arteries of 50–60%, well below the 95% saturation in the
adult. Oxygen content of the blood and its release to the tissues
also depends on the hemoglobin (red blood cell) concentration
(the amount of O2 dissolved in plasma is relatively negligible,
 0.3 ml/100 ml, but can account for 10% of total oxygen in
the early embryo when blood hemoglobin concentrations are
low). Also important to oxygen content and release are the char-
acteristics of the fetal hemoglobins, which have higher O2
affinities and greater sensitivity to CO2 and protons compared
with adult mammal hemoglobin [reviewed in (11, 110)]. To
summarize, the fetal mammalian blood carries less O2 than that
of the adult, giving rise to the generalization that the embryo
and fetus develop in a relatively hypoxic environment.
Similar principles apply to the oxygen content in developing
avians. The partial pressure of oxygen in the chicken embryo
systemic arteries, 40–50 mm Hg, tends to be higher than that
of the developing mammalian embryo, but the calculated he-
moglobin saturation of 37% is similar [reviewed in (6, 64)].
Thus, the O2 content of the early chicken embryo’s arterial
blood is very low, 1–2  l O2/100  l blood, as compared with
adult values of  15 ml/100 ml blood. The pO2 values in ve-
nous blood and in tissues are also very low, suggesting (a) that
the tissues are consuming much of the available O2, and (b) that
little O2 reserve remains in the system.
Indicators of O2 deprivation within cells 
and tissues
The adequacy of the O2 supply to the developing tissues is
dependent on the O2 delivery versus the O2 demand of the tis-
sues. Direct measurement of O2 demand and O2 concentrations
within intact cells and tissues in vivo is problematic. Anaero-
bic metabolism, as evidenced by lactate production, is one sur-
rogate indicator of tissue hypoxia. So too is the nitroimadazole
class of chemicals, such as 2-(2-nitro-1H-imidazol-1-yl)-N-
(2,2,3,3,3-pentafluoropropyl) acetamide (EF5) and pimibenda-
zole, which form adducts in cells in a chemically reducing
environment [i.e., their binding is logarithmically inversely
proportional to O2 concentration (31)]. These chemicals are
thus used as indicators of O2 gradients among cells, but be-
cause of differences in binding activities between cells, com-
parisons between different cell types are problematic. A sec-
ond indicator of hypoxia is HIF-1 itself. Expression of the
HIF-1  (ARNT) subunit is constitutive. The HIF-  subunits
are regulated by hypoxia through the action of PHDs (discussed
earlier). Accumulation of HIF-  protein indicates relative hy-
poxia, with the caveat that HIF-  protein may be induced by
O2-independent mechanisms. A related and potentially very
useful indicator was recently developed in which the oxygen
degradation domain (ODD) of HIF-1  was fused to the lucif-
erase reporter. In these mice, the readily measurable luciferase
serves as a reporter for O2 gradients (84). A third indicator of
tissue hypoxia is the accumulation of hypoxia/HIF-dependent
transcripts and the processes that they control. A large num-
ber of such genes have been identified, based on mostly in vitro
studies [for example, (28, 61) and a few in vivo studies (59)
of tissue hypoxia]. Many more studies have examined the ef-
fects of tissue ischemia, in which reductions in blood flow re-
sult in oxygen and substrate deprivation and accumulation of
metabolic wastes, a topic beyond the scope of this review. The
hypoxia-dependent transcriptional program may control cell
autonomous hypoxic responses, such as glycolysis and cell
death and survival [reviewed in (44, 72)], and noncell au-
tonomous responses such as angiogenesis and erythropoiesis,
to restore O2 delivery to meet oxygen demands. We now con-
sider how relative tissue hypoxia, acting through an HIF-de-
pendent transcriptional program, may drive specific mor-
phogenic processes in the heart.
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Role of tissue hypoxia in cardiac outflow tract de-
velopment. The outflow portion of the heart has developed
considerable complexity through evolution, as noted earlier. For
a review of its development in higher vertebrates see (1, 39, 52,
79, 81, 98). In birds and mammals, myocardium is added to the
arterial pole of the heart from a secondary or anterior heart-
forming field, well after the primary heart tube has formed. In
Fig. 5, the completed OFT myocardium of the stage 25 em-
bryonic chick heart is labeled with a red fluorescent protein tag.
At this stage of development, the avian heart (and mammalian
heart at a comparable stage of development) resembles the
more-primitive single-chamber configuration discussed earlier,
in which blood flows into a single ventricle through a single
atrial chamber and is pumped out through an unseptated OFT
into the aortic sac. This outflow portion of the heart subse-
quently undergoes complex remodeling in the transition to a
dual in-series circulation. The remodeling includes
1. the shortening of the OFT myocardium, and the rotation of
the aorta to a posterior position where it will directly con-
nect with the left ventricle (stage 25 vs. 36; see Fig. 5). The
shortening and rotation of the OFT in avians requires the
elimination of OFT cardiomyocytes by programmed cell
death (107, 108) (Fig. 6);
2. the septation of the OFT and “aortic sac” into pulmonic and
systemic (aortic) vessels, a process dependent on invasion
by cells from the neural crest (54);
3. the recruitment of endothelial progenitor cells (see Fig. 6),
which will be organized to form the coronary arteries (50,
96) [reviewed in (103)]; and
4. the remodeling of the cushion mesenchyme to form the semi-
lunar (aortic and pulmonary) valves and part of the ventric-
ular septum in mammals.
We hypothesized that tissue hypoxia may play a role in the re-
modeling of the OFT in chicken embryos based on two observa-
tions: (a) the high incidence of programmed cell death (PCD) in
the cardiomyocytes of the OFT during its remodeling (107), and
(b) the recruitment of endothelial progenitor cells to the OFT and
their organization into a coronary vascular plexus approximately
synchronous with the PCD-dependent remodeling of the OFT (82).
Because cell survival/death and vasculogenesis both may be re-
sponses to tissue hypoxia [reviewed in (8)], O2 gradients were ex-
amined by using the surrogate markers EF5 and HIF-1  (96–98,
109). EF5 was injected into the vitelline vein of chicken embryos
and detected with a Cy3-conjugated monoclonal antibody. HIF-
1  protein was detected with a polyclonal antibody and TSA sig-
nal amplification. Good correspondence was found between EF5
and HIF-1  signals (Fig. 7). Each was first detected in the OFT
myocardium at stage 25, increased to a peak at stage 30, and then
subsided to background levels by stage 32. This staining was re-
stricted to the OFT myocardium (see Fig. 7) and several other lo-
cations (see later) and showed the appropriate responses when the
eggs were incubated under hypoxia (7.5% O2 for 6 h) or hyper-
oxia (95% O2 for 24 h). These results suggest that the chicken em-
bryo OFT myocardium is hypoxic relative to the other chamber
myocardium specifically at the stages of PCD-dependent remod-
eling of the OFT in the transition to a dual circulation.
Why specifically the embryonic chicken OFT myocardium
is relatively hypoxic is suggested by anatomic considerations.
The coronary arterial system that is dedicated to supplying O2
to the myocardium does not become functional until after stage
32 (106). Before this, O2 supply to the myocardium occurs by
diffusion from the blood within the chamber, resembling the
arrangement in the more-primitive vertebrate hearts reviewed
earlier. The ventricles of the embryonic chicken heart are highly
trabeculated with a relatively thin myocardium. The high de-
gree of trabeculation increases the surface area/mass ratio of
the myocardium, and thus facilitates O2 and substrate diffusion
into the myocardium. The OFT myocardium does not become
trabeculated and instead is adjacent to a thick endocardial mes-
enchyme, visible in Fig. 7, that will subsequently be remodeled
to form the semilunar valves and other structures. The thick-
ness of this mesenchyme, several hundred micrometers, likely
represents a significant barrier to O2 diffusion to the adjacent
myocardium, given the estimates of the limits of O2 diffusion
through respiring tissues of  100 microns in thickness (73). O2
diffusibility varies between tissues and cell types, depending on
the O2 gradient produced by tissue O2 consumption and on the
presence of proteins such as myoglobin in cardiac (and skele-
tal) muscle that serve as a significant O2 store. In summary, the
binding of EF5 and accumulation of HIF-1  in the stage 25–32
OFT myocardium suggest that the O2 supply is inadequate and
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FIG. 6. Key cellular processes in avian heart morphogene-
sis. OFT cardiomyocytes are eliminated by apoptosis, as in-
dicated by LysoTracker Red (LTR) staining (arrow), observed
in this whole-mount picture of a stage 25 quail heart. Endo-
thelial progenitor cells, detected with an anti-QH1 antibody, are
observed within the epicardial tissue covering the ventricle (ar-
row) and are recruited to the OFT, where they will be orga-
nized into a vascular network. The chamber endocardial endo-
thelium is also QH1 positive. (For interpretation of the
references to color in this figure legend, the reader is referred
to the web version of this article at www.liebertonline.com/ars)a reducing environment is present within these cells, likely due
to the unique structural arrangements of this region of the heart.
That O2 is critical to the developmental remodeling of the
avian cardiac OFT development is supported by experiments in
which the O2 supply is altered. Of note, in very early stages of
development, the dependence on diffusion for a supply of O2
appears not to be a limitation to continuing growth and devel-
opment. Chicken embryo development (and development of
other vertebrates) can proceed normally in the complete absence
of blood convection until eventually the embryonic metabolic
rate outstrips diffusional mechanisms for oxygen and nutrient
supply (13, 18). At the later stages of development (HH 25–32),
reduction of ambient O2 concentrations to 5–7.5% (from 21%)
results in demise of the embryo because of circulatory arrest
within hours (96, 97). In contrast, more-modest degrees of hy-
poxia (12–15%) are tolerated by the embryo, but have little ef-
fect on O2 supply, likely because of adaptations to maintain O2
supply to the tissues (7). Incubation of the eggs under high con-
centrations of O2 (95%), thereby blunting the hypoxia in the
OFT myocardium, results in conotruncal (i.e., OFT) heart de-
fects, suggesting that hypoxia in the OFT myocardium is nec-
essary for the proper remodeling of the OFT. However, these
experiments must be interpreted with caution because (a) the
entire egg is exposed to increased O2, and (b) the increased O2
could result in the generation of toxic reactive oxygen species
(i.e., have an effect independent of hypoxic blunting).
A mechanistic understanding of how hypoxia may regulate
the PCD-dependent remodeling of the OFT requires the target-
ing of HIF and the hypoxia-dependent transcriptional program
specifically in the cells of the OFT. Genes can be specifically
targeted to the OFT cardiomyocytes of the chicken embryo by
using an adenoviral gene-delivery system (34, 35). Recombi-
nant replication-defective adenoviruses are injected into the
pericardial space of the stage 15–17 chick embryo in ovo when
the epicardial surface of the heart is a bare myocardium. Using
the CMV enhancer and promoter specifically drives gene ex-
pression in the OFT cardiomyocytes, providing a way to target
these cells specifically. Adenoviral-mediated forced expression
of a constitutively active HIF-1  construct [described in (51)],
or short exposures to moderate degrees of global hypoxia
(5–7.5% O2) that do not cause the demise of the embryo, do
not result in increased programmed cell death of the OFT car-
diomyocytes. Hypoxia may trigger cardiomyocyte cell death in
other settings [reviewed in (8)], and perhaps the moderate de-
gree of hypoxia in this model is not sufficient to trigger a cell-
death response. Preliminary studies suggest that the forced ex-
pression of HIF-1  actually protects the cardiomyocytes of the
OFT from programmed cell death (data not shown). One po-
tential prosurvival target of HIF-1  in this context is the VEGF
receptor (VEGFR2). VEGFR2 is selectively expressed by the
cardiomyocytes of the OFT during the stages of tissue hypoxia,
and the survival of the OFT cardiomyocytes is dependent on
the activity of a kinase downstream of VEGFR2 termed Akt
(96). VEGFR2 has also been shown to be upregulated in ma-
ture muscle and other parenchymal cells in response to O2 de-
privation/ischemia (49, 68, 80). These observations suggest that
VEGF/VEGFR2 signaling may have originally evolved as an
autocrine mechanism for cell survival under hypoxic stress. It
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FIG. 7. The nitroimidazole EF5 and HIF-1    protein indicate hypoxic regions of the stage 30 (ED6) embryonic chicken
heart. After infusion of EF5, binding was detected with a Cy3-conjugated anti-EF5 monoclonal antibody. The section was co-
stained with Sr-1, an antibody against sarcomeric a-actin, to delineate the myocardium. HIF-1  was detected with a polyclonal
antibody followed by TSA amplification. Good agreement is seen in the distribution of the signals for EF5 and HIF-1 , indi-
cating relatively hypoxic regions of the developing heart in the myocardium of the OFT and AV junction. Note that the liver is
also intensely EF positive. Bars, 500 μm. PA, pulmonary artery; Ao, aorta; Vent, ventricle; At, atrium; myo, myocardium; OFT,
outflow tract. [Reprinted with permission from Developmental Dynamics (109) and Developmental Biology (97)]. (For interpre-
tation of the references to color in this figure legend, the reader is referred to the web version of this article at www.lieberton-
line.com/ars)is now better known as a paracrine signal to stimulate angio-
genesis in ischemic tissues and is also a vascular permeability
factor. A similar scenario has been suggested for erythropoietin
(EPO)/EpoR signaling, which is required in the embryo for he-
matopoiesis and thus O2 delivery and cell/embryo survival
(112), but also seems to function in an autocrine cell-survival
pathway (113). Hypoxia signaling through HIF and other mech-
anisms may regulate the expression of a number of prosurvival
and prodeath genes (3, 25, 26, 56, 78, 93). The elucidation of
the role of the broader array of the HIF/hypoxia-dependent gene
program in the death or survival of the OFT cardiomyocytes
awaits further investigation.
Several other processes are required for the remodeling of
the OFT in the transition to the mature dual in-series circula-
tion. One is the septation of the OFT into distinct pulmonary
and systemic arteries, a process dependent on migration of cells
from the neural crest into the OFT [reviewed in (47)]. The in-
vasion of the heart by the neural crest cells is dependent on neu-
ropilins and semaphorins (12), signaling proteins related to the
VEGF family. VEGF also has been suggested to regulate neg-
atively the formation of AV mesenchymal cushions (27), a tis-
sue that will be remodeled to form the valves. Similarly, the re-
cruitment of the endothelial progenitor cells and formation of
the coronary arteries at the base of the OFT appears to be un-
der the control of VEGF (103). Thus, it is tempting to specu-
late that the O2 deprivation in the embryonic OFT has a field
effect, leading to its remodeling into the adult structures, a hy-
pothesis that may be tested with targeted gain- and loss-of-func-
tion experiments. A number of other signaling pathways have
also been shown to play a role in these various processes in the
OFT, and the role of hypoxia will have to be considered within
the broader context of these signaling pathways and cell–cell
interactions.
Vasculogenesis and angiogenesis. The formation
of new blood vessels, either by de novo assembly of endothe-
lial progenitor cells (vasculogenesis), or by extension from pre-
existing vessels (angiogenesis), is the prototypic hypoxic re-
sponse to restore oxygen supply to a tissue (21, 67, 91). Not
much investigation has been done on the extent to which tis-
sue hypoxia, or oxygen gradients, arising during normal devel-
opment, drive blood-vessel formation in the embryo. Inactiva-
tion of a number of hypoxia-responsive genes in the mouse
germline cause mid-gestation death (see later), consistent with
a potential role for tissue hypoxia. However, because most hy-
poxia-responsive genes are also regulated by other factors, the
observed defects in these embryos cannot with confidence be
attributed to an effect of tissue hypoxia. In the developing
chicken heart, at the same time that the OFT cardiomyocytes
are experiencing hypoxic stress, EPCs are recruited to the car-
diac OFT via the proepicardial tissue (97), form a peritruncal
vascular plexus (50, 97), and are reorganized to form the coro-
nary vessels [reviewed in (77)]. These cells are also VEGFR2
positive, and VEGFR2 is essential to the process of develop-
mental vasculogenesis (see later). Whether the processes of
PCD-dependent OFT remodeling and coronary vasculogenesis
are mechanistically linked, particularly in relation to hypoxia,
or merely coincidental, requires further investigation. An in-
creasing gradient of EF5 binding and HIF-1  protein is also
observed in the ventricular myocardium from endocardium to
epicardium (97, 109); any relation of this gradient to the cov-
erage of the epicardial surface with epicardial mesenchyme con-
taining vascular progenitors, and the formation of the vessels
within the ventricular myocardium, will require further study.
Increased EF5 binding is also observed (a) in the myocardium
of the atrioventricular junction (109) (Fig. 7), suggesting that
hypoxia could also play a role in the developmental remodel-
ing of this structure and its underlying mesenchyme; and (b) in
the ventricular septum, particularly at the site of formation of
the AV node/bundle of His. As yet no data exist as to whether
hypoxia plays a role in the development of the specialized car-
diac conduction system, another relatively late development in
the evolution of the cardiovascular system.
Mammalian heart development. The indicators of
relative tissue hypoxia, EF5 binding, and HIF-  accumulation
show similar distributions in the mouse embryo (5), as described
for the chick earlier. Thus, the OFT myocardium and ventric-
ular septum are EF5 and HIF-1  positive at ED11–14, the pe-
riod of remodeling of the OFT in the transition to a dual cir-
culation in the mouse embryo that corresponds to stage 25–32
(ED5–8) of chicken development. This is also the develop-
mental period in the mouse for the formation of the coronary
vessels. One observation from mouse development that was not
noticed in the chicken embryo was the striking accumulation
of EF5 in the forming aorticopulmonic septum. Whether this
represents relative hypoxia of this tissue, and whether this may
also be true in the chicken embyro, requires further study.
No analysis exists of the developing mammalian heart and
vascular structures of a possible correlation of the hypoxic re-
gions of the heart with the expression of hypoxia-inducible
genes, or the extent to which these genes may be regulated by
hypoxia/HIF. This will be important to establish to interpret the
results of mouse gene gain- and loss-of-function studies in the
context of the proposed model of hypoxia-dependent cardiac
morphogenesis. A number of gene loss-of-function, and fewer
change-of-function or gain-of-function experiments, have been
performed in the mouse with hypoxia-responsive genes. The
deletion of HIF-1  or   genes in the mouse germline results in
death at ED10–14 [reviewed in (88, 92)], when the embryonic
cardiovascular system is beginning to function in O2 and sub-
strate delivery to the tissues. The cell or tissue type for which
deletion of the hypoxia-inducible HIF-  is catastrophic to the
embryo has yet to be clearly defined, and any defect in the vas-
cular system, including the placenta, with resultant effects on
oxygen delivery, is likely to have pleiotropic effects on the em-
bryo. Similarly, the germline inactivation of other HIF-related
and hypoxia target genes, such as PHD2 (reviewed earlier) and
the Von Hippel–Lindau protein, which like PHD2 is required
for the degradation of HIF-  under normoxia [reviewed in (42)]
also results in the death of the embryo between ED10 and 14,
almost certainly due to the embryo’s growing need for O2 and
substrates at this stage of development.
The early lethality of embryos with deletion of HIF- , as
well as the likely pleiotropic effects of vascular (placental) in-
sufficiency, confounds the study of the role of hypoxia in or-
gan morphogenesis and vasculogenesis by using germline gene
inactivation. A more targeted strategy for gene inactivation has
been developed in which the gene is inactivated in specific cell
types. This is the Cre-Lox technology, in which a portion of
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Cre recombinase is expressed from a tissue-specific promoter
driving expression in the cells of interest. A mouse carrying the
Cre transgene is then crossed with a mouse with the floxed al-
leles, resulting in tissue-specific inactivation of the gene with
varying efficiency. This approach has been used to alter the ex-
pression of a limited number of genes in the hypoxia signaling
pathway within specific cell types in the developing heart and
vascular system.
Deletion of a floxed HIF-1  gene restricted to the embryonic
ventricular myocardium by using the MLC2vCre driver did not
affect viability and produced a mild ( 15%) reduction in the
vascularity of the mature myocardium (46). Although one could
conclude that no major role for HIF exists in the embryonic
ventricular myocardium, confounding factors in gene-inactiva-
tion studies may include family member redundancy, cell and
physiologic compensations and adaptations within the embryo,
issues in the timing of gene inactivation relative to morpho-
genesis, and efficiency of inactivation of the gene and its pro-
tein product. In a study using a different floxed HIF-1  allele,
neural-specific inactivation of HIF-1 by using nes-Cre resulted
in a much greater reduction in vessel density (80%) in the
brain’s ventral cortical plate associated with apoptosis of the
neuronal cells (104). As a reduction in VEGF was found in the
brains of these mice, this suggests that brain parenchymal hy-
poxic induction of HIF-1 and VEGF is required to generate a
vascular supply to this organ. Alternatively, or in addition, these
results could also be consistent with VEGF promoting survival
of the neuronal cells through autocrine signaling.
We now turn our attention to the gene targets of HIF. Inac-
tivation of VEGF or the VEGF receptor (VEGFR2) in the
germline is embryonic lethal [reviewed in (23)]. Inactivation of
floxed VEGF alleles in the ventricular myocardium by using
the MLC2vCre driver resulted in nonviability with partial pen-
etrance, myocardial thinning, and 50% reduction in myocardial
capillary density (38). The large epicardial coronary arteries
were normal. These results suggest that VEGF transcribed in
the embryonic ventricular cardiomyocytes is necessary for the
formation of the microcirculatory vessels, similar to a conclu-
sion reached in experiments with germline inactivation of HIF-
1  (83). A similar conclusion was reached when VEGF was
inactivated in the brain neuronal cells by using the nes-Cre dri-
ver, in which guidance of capillary growth to the brain paren-
chyma was defective (74). VEGF gain-of-function, induced by
insertion of a LacZ transgene at the 3  end of the transcript, re-
sulted in lethality at ED12–14 with thinned myocardium, di-
lated epicardial vessels, and defects in OFT septation (65). At
least four isoforms of VEGF-A are produced by alternative
splicing of exons [reviewed in (22)]. VEGF change of function,
produced by inserting a specific isoform into the VEGF ge-
nomic locus, also caused lethality and cardiovascular defects.
Mice that only expressed the 120-kDa or 188-kDa isoforms of
VEGF had OFT defects, including a spectrum of defects in the
ventriculoarterial connections and in the remodeling of the aor-
tic arches (94). Some of these defects resembled those seen in
congenital human heart defects such as tetralogy of Fallot, per-
sistent truncus arteriosus, and DiGeorge syndrome (see Fig. 4).
These studies demonstrate that the developing cardiovascular
system is exquisitely sensitive to changes in VEGF activity, and
also suggest that alterations in hypoxia-dependent morphogen-
esis in the developing cardiovascular system could play a role
in congenital human heart defects. Another signaling system
that is induced by hypoxia and recruits endothelial progenitors
to sites of hypoxia is the SDF-1 ligand/CXCR4 receptor sig-
naling system (20). SDF-1 expression in the developing heart
(63) appears to overlap with regions of tissue hypoxia, although
a direct comparison has not been made. Germ-line deletion of
SDF-1 results in embryonic or neonatal lethality and a mem-
branous ventricular septal defect (66), suggesting that this sig-
naling system could be involved in heart septation or other mor-
phogenetic processes.
Erythropoietin, as its name implies, is the primary hormone
responsible for erythropoiesis throughout life, and its expres-
sion is highly regulated by hypoxia and HIF. In addition to its
function in stimulating erythropoiesis, erythropoietin also has
an autocrine function to promote cell survival under hypoxic
stress (10, 53, 113), a striking analogy to the VEGF proposed
paracrine and autocrine functions reviewed earlier. The
germline deletion of Epo or the Epo receptor results in mid-
gestation lethality. Although these embryos are severely ane-
mic, it has been suggested that part of the lethality is due to the
abrogation of the autocrine growth effect of Epo on the
parenchymal cardiomyocytes (112) and neuronal cells (113).
Given that these embryos have reduced O2 delivery secondary
to anemia, the sorting out of the extent to which the defects in
heart and brain development are primary or secondary will re-
quire tissue-restricted gene-inactivation experiments.
CONCLUSIONS
The cardiovascular system has evolved over millions of years
to optimize its function in O2 and substrate delivery matched
to the metabolic demands of the tissues that it serves. As ani-
mals became larger and more complex, with greater energy de-
mands, the demand for O2 increased. Key developments that
facilitated increased O2 delivery were pigments to increase O2
carrying capacity and the separation of oxygenated and deoxy-
genated blood in a dual in-series circulation. A number of lines
of investigation suggest that the adaptations of the developing
avian and mammalian embryo to O2 gradients in a relatively
hypoxic environment may play a critical role in the formation
of specific heart and vascular structures, such as the OFT, coro-
nary vessels, and placenta.
Although a great deal is known about OFT formation in ver-
tebrate hearts, many pressing questions remain. We believe that
the following topics are ripe for investigation:
• What are the molecular mechanisms by which hypoxia may
trigger the remodeling of the embryonic cardiac OFT?
• Does a direct or indirect role exist for tissue hypoxia in the
morphogenesis of other cardiovascular structures where EF5
staining/HIF-1a is observed, such as the atrioventricular junc-
tion, the cushion mesenchyme, and the conduction system?
• What might be the role of developmental tissue hypoxia in
the phylogenetic differences in the cardiac outlet and other
structures?
• Do mutations in the genes in the hypoxia signaling pathway
relate to congenital structural heart disease?
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ceptible to disruption by oxygen deprivation or oxidant
stress?
Answering these and related key questions should rapidly
advance our understanding of heart and OFT morphology, evo-
lution, development, and disease.
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dazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide; EPC,
epithelial cell; Epo, erythropoietin; HIF, hypoxia-inducible
transcription factor; LV, left ventricle; OFT, cardiovascular out-
flow tract; MLC2vCre, myosin light-chain 2v Cre; PA, pul-
monary artery; PCD, programmed cell death; PHD, prolyl 4-
hydroxylases; RV, right ventricle; VEGF, vascular endothelial
growth factor.
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